Improvement of dissolution properties of furosemide by complexation with β-cyclodextrin

Drug Development and Industrial Pharmacy

Volumn 24, Issue 1, 1998, Pages 19-25

  Özdemir, Nurten ^a   Ordu, Şefika ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CYCLODEXTRIN; FUROSEMIDE;

ARTICLE; BIOAVAILABILITY; COMPLEX FORMATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; NONHUMAN; X RAY DIFFRACTION;

EID: 0031938330     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049809082348     Document Type: Article

References (8)

1. M. M. Hammarlund, L. K. Paalzow, and B. Odlind, Eur. J. Clin. Pharmacol., 26, 197-207 (1984).
2. V. S. Chungi, L. W. Dittert, and R. B. Smith, Int. J. Pharm., 4, 27-38 (1979).
3. D. Duchene and D. Wouessidjewe, Acta Pharm. Technol., 36, 1-6 (1990).
4. O. Bekers, E. V. Uijtendaal, J. H. Beijnen, A. Bult, and W. J. M. Underberg, Drug Dev. Ind. Pharm., 17(11), 1503-1549 (1991).
5. P. Mura, A. Liguori, G. Bramanti, G. Bettinetti, E. Campisi, and E. Faggi, Eur. J. Pharm. Biopharm., 38(3), 119-123 (1992).
6. G. A. El-Gendi, M. G. Abdel-Mohsen, and T. H. El-Faham, Eur. J. Pharm. Biopharm., 38, 124-128 (1992).
7. M. Kata and G. Kedvessy, Pharm. Ind. 49, 98-100 (1987).
8. T. Higuchi and K. A. Connors, Adv. Anal. Chem. Instrum., 4, 117-212 (1965).